WO2007013581A1 - Sedative composition - Google Patents

Sedative composition Download PDF

Info

Publication number
WO2007013581A1
WO2007013581A1 PCT/JP2006/314958 JP2006314958W WO2007013581A1 WO 2007013581 A1 WO2007013581 A1 WO 2007013581A1 JP 2006314958 W JP2006314958 W JP 2006314958W WO 2007013581 A1 WO2007013581 A1 WO 2007013581A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
group
hydrogen atom
general formula
sleep
Prior art date
Application number
PCT/JP2006/314958
Other languages
French (fr)
Japanese (ja)
Inventor
Yasuyuki Hasegawa
Original Assignee
Kobayashi Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2005219377A external-priority patent/JP4632895B2/en
Priority claimed from JP2006035834A external-priority patent/JP2007031421A/en
Application filed by Kobayashi Pharmaceutical Co., Ltd. filed Critical Kobayashi Pharmaceutical Co., Ltd.
Publication of WO2007013581A1 publication Critical patent/WO2007013581A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Definitions

  • the present invention relates to a sedative composition. More specifically, the present invention relates to a sedative composition that excels in the action of calming the spirit of humans and animals.
  • sandalwood has been rapidly decreasing in number in recent years due to overcutting, and sandalwood oil produced from the plant moss has been steadily decreasing. With such a decrease in the production of sandalwood oil, the development of synthetic compounds exhibiting the same scent as sandalwood oil is being energetically promoted today.
  • the sedative effect of sandalwood oil has no direct causal relationship with the smell of smelled sandalwood oil, and it is a compound that exhibits the same or similar scent as sandalwood.
  • the current situation is Tatsuno.
  • Patent Document 1 Japanese Patent Laid-Open No. 7-316582
  • Patent Document 2 Japanese Patent Publication No. 7-57734
  • An object of the present invention is to provide a composition for sedation which is excellent in the action of sedating a human or animal spirit.
  • the present invention provides the following inventions:
  • R to R are the same or different and each represents a hydrogen atom, a hydroxyl group or a methyl group;
  • 9 is the same or different and represents a hydrogen atom or a methyl group
  • A represents an ethylene group or a beylene group, and n represents an integer of 0 to 10]
  • a sedative composition comprising: a sedative composition.
  • Item 2 The composition for sedation according to Item 1, wherein in General Formula (1), at least three of R to R are acetyl groups.
  • R to R are all methyl groups, and R to R are all hydrogen atoms.
  • Item 2 The sedative composition according to Item 1.
  • Item 2 A sedative composition according to Item 1.
  • Item 5 The sedative composition according to Item 1, wherein n is 0 to 2 in the general formula (1).
  • R to R are all methyl groups, and R to R are all hydrogen atoms.
  • Item 2 The sedation according to Item 1, wherein one or both of R and R are acetyl groups.
  • R ⁇ R cation group R ⁇ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
  • R ⁇ R force S methyl group R ⁇ R is hydrogen atom, R and R force S methyl group, A is beylene group,
  • n 0
  • Item 2 The sedative composition according to Item 1.
  • Item 8 In the sedative composition, the ratio of the compound represented by the general formula (1) to the total amount of the compound represented by the general formula (1) and the fragrance component is 10% by weight or more. Item 8. A sedative composition according to any one of items 1 to 7,
  • Item 9 The sedative composition according to any one of Items 1 to 8, which is in the form of a fragrance, a cosmetic, an inhalation agent, a textile detergent, or a food.
  • R to R are the same or different and each represents a hydrogen atom, a hydroxyl group or a methyl group,
  • R and R are the same or different and each represents a hydrogen atom or a methyl group
  • A represents an ethylene group or a beylene group
  • n an integer of 0 to 10]
  • a composition for improving sleep comprising:
  • Item 11 The sleep improving composition according to Item 10, wherein, in General Formula (1), at least three of R to R are methyl groups.
  • R to R are all methyl groups, and R to R are all hydrogen atoms.
  • Item 11 The composition for improving sleep according to Item 10, which is a child.
  • Item 11 The composition for improving sleep according to Item 10.
  • Item 14 The composition for improving sleep according to Item 10, wherein n force ⁇ -2 in the general formula (1).
  • Item 15. In the general formula (1), R to R are all methyl groups, and R to R are all hydrogen atoms.
  • R ⁇ R cation group R ⁇ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
  • R ⁇ R cation group R ⁇ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
  • R ⁇ R force S methyl group R ⁇ R is hydrogen atom, R and R force S methyl group, A is beylene group,
  • n 0
  • Item 11 The composition for improving sleep according to Item 10, wherein
  • Item 17 In the composition for improving sleep, the ratio of the compound represented by the general formula (1) to the total amount of the compound represented by the general formula (1) and the fragrance component is 10% by weight or more. Item 17. The composition for improving sleep according to any one of Items 10 to 16.
  • Item 18 The sleep improving composition according to any one of Items 10 to 17, which is in the form of a fragrance, a cosmetic, an inhalation agent, a textile detergent, or a food.
  • the “sedative composition” is used to relax or improve sleep by soothing the mind of a human or animal.
  • the “sleep improvement composition” refers to a good sleep state that induces sleep by improving sleepiness when waking up, smoothing sleep, reducing arousal during sleep, etc. Is used to guide
  • the sedative composition of the present invention is characterized by containing a compound of the following general formula (1).
  • I ⁇ to R 7 are the same or different and are a hydrogen atom, a hydroxyl group or a methyl group, preferably a hydrogen atom or a methyl group.
  • at least three of R to R are preferably acetyl groups, particularly R methyl group and R
  • All of ⁇ R are preferably hydrogen atoms.
  • R and R are the same or different and each represents a hydrogen atom or a methyl group.
  • either one or both of R and R are S methyl groups.
  • A represents an ethylene group (CH 2 —CH 2) or a beylene group (CH ⁇ CH).
  • n is an integer of 0 to 10. In the compound of the general formula (1), preferably n is
  • n 0 or 1
  • n is 0.
  • R ⁇ R cation group R ⁇ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
  • n 0 (ie, 3-methyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -pentan-2-ol);
  • R ⁇ R cation group R ⁇ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
  • R ⁇ R force S methyl group R ⁇ R is hydrogen atom, R and R force S methyl group, A is beylene group, and
  • the compound represented by the general formula (1) is a known compound or a compound that is easily derived from a known compound power.
  • the compound represented by the general formula (1) is produced by various known synthetic methods depending on the basic skeleton, the type of substituents, and the like.
  • the compound represented by the general formula (1) is a compound represented by the following general formula (2) (wherein R
  • ⁇ R and n are the same as described above) and an appropriate aldehyde or ketone is subjected to aldol condensation under appropriate conditions, and further reduced under appropriate conditions.
  • the compound represented by the general formula (2) used as the raw material mixture of the compound represented by the general formula (1) is a known compound or a compound easily derived from the known compound. is there.
  • the compound represented by the general formula (2) is camphorolenal (campholenicaldehyde; a compound in which R to R force S methyl group, R to R is hydrogen atom, n force SO in general formula (2)) Even if camphorolenal (campholenicaldehyde; a compound in which R to R force S methyl group, R to R is hydrogen atom, n force SO in general formula (2)) Even if camphorolenal (campholenicaldehyde; a compound in which R to R force S methyl group, R to R is hydrogen atom, n force SO in general formula (2)) Even if camphorolenal (campholenicaldehyde; a compound in which R to R force S methyl group, R to R is hydrogen atom, n force SO in general formula (2)) Even if camphorolenal (campholen
  • a pinene ( ⁇ -pinene) can be epoxidized, and the resulting epoxide can be reacted in the presence of ZnBr under appropriate conditions.
  • one compound may be used alone, or two or more compounds may be used in any combination. You can do it.
  • the compound represented by the general formula (1) includes a compound that itself exhibits a sandalwood fragrance.
  • a component exhibiting aroma such as an essential oil component or a synthetic fragrance obtained from natural plants and animals by an existing extraction method (hereinafter referred to as a fragrance composition) , "Denoted as" perfume ingredient ").
  • the total amount of the compound represented by the general formula (1) and the fragrance component fragment components other than the compound represented by the general formula (1).
  • the compound represented by the general formula (1) is preferably 10% by weight or more, preferably 40% by weight or more, and more preferably 70% by weight or more.
  • the sedative composition of the present invention may be composed of only the compound represented by the general formula (1), but depending on the form of use, it may be a carrier, a substrate, an additive, or the like. Other components may be contained.
  • the ratio of the compound represented by the general formula (1) depends on the use form of the composition, the degree of expected effect, the gender and age of the user, etc. Although different, for example, the ratio of the compound represented by the general formula (1) to 0.01 to L00% by weight, preferably 0.05 to 80% by weight, with respect to the total weight of the composition.
  • the form of the sedative composition of the present invention is not particularly limited as long as the compound represented by the general formula (1) is prepared so as to be inhaled or absorbed.
  • Specific examples of the form of the sedative composition of the present invention include fragrances, cosmetics, inhalation administration agents, textile detergents, foods and the like. Preferred are fragrances, cosmetics, inhalation administration agents, and textile products, and more preferred are fragrances and cosmetics.
  • fragrances examples include those for which conventional power is also used as fragrances, such as for bedrooms, living rooms, toilets, entrances, bathrooms, closets, and chiffons.
  • the form of the fragrance is not limited, and various forms such as a solid form, a semi-solid form (jelly form, gel form, etc.), a liquid form, and an aerosol form are used.
  • the fragrance may be used by spontaneously evaporating the compound represented by the general formula (1), or the compound may be evaporated by heating. In particular, if the compound represented by the general formula (1) is poor in volatility, it is desirable to evaporate by heating.
  • the sedative composition of the present invention is conventionally used as a fragrance in addition to the compound represented by the general formula (1).
  • Ingredients such as the base, support, additive, etc., can be contained.
  • the base compounded in the fragrance include water, ethanol, solid or liquid anionic, cationic, nonionic active agent, polymer agent, fats and oils, guar gum, xanthan gum, gum arabic, and dielan gum.
  • the sedative composition of the present invention is in the form of a fragrance
  • a particularly suitable blending ratio of the compound represented by the general formula (1) is represented by the general formula (1) in the composition.
  • the proportion of the compound is 5 to 80% by weight, more preferably 40 to 60% by weight.
  • cosmetics include biological cleaning agents such as sarcophagus, bathing agents, and the like.
  • Specific examples of cosmetics include creams, milky lotions, cosmetic powders, body lotions, hair styling, hair shampoos, sarcophagus, body soaps, antiperspirants, shampoos, rinses, perfumes, lotions, toothpastes, liquid toothpastes, washing Examples include mouth preparations, mouse pets, sunscreens, kitchen detergents, massage oils, massage creams, skin care oils, and the like.
  • the sedative composition of the present invention is represented by the general formula (1).
  • components such as bases and additives conventionally used in cosmetics can be contained.
  • the base is not particularly limited, and examples thereof include water, ethanol, talc, gelatin, wax, petrolatum, and lanolin.
  • the additive is not particularly limited, and examples thereof include humectants, skin softeners, preservatives, solubilizers, and fragrances.
  • a particularly suitable blending ratio of the compound represented by the general formula (1) is represented by the general formula (1) in the composition.
  • the proportion of the compound is 0.01 to 50% by weight, more preferably 0.05 to 10% by weight, and still more preferably 0.1 to 1% by weight.
  • An inhalation administration agent is a preparation in which the compound represented by the above general formula (1) is volatilized in the vicinity of the nose or applied to the nasal cavity to intentionally inhale the compound. Examples include nasal sprays, sprays, inhalation solutions, and masks carrying the compounds.
  • the sedation composition of the present invention is in the form of an inhalation administration agent, the sedation composition of the present invention has been conventionally used for an inhalation administration agent in addition to the compound represented by the general formula (1). Ingredients such as bases and additives can be included.
  • an inhalation gas is used, the gas that has been used in conventional inhalation administration agents can be used. Administration of the inhalation agent
  • the inhalation administration agent is a compound power represented by the above general formula (1) in the inhaled gas at the time of use, usually 0.000001 ppm to 10 ppm, preferably O.OOOOlppm to 0.1 ppm, It is desirable to set appropriately so as to volatilize at a concentration of about 0.0001 ppm to 0.001 ppm.
  • textile detergents include anionic, cationic, nonionic or zwitterionic detergents, textile softeners, textile softeners, dryer textile softeners, and the like. Can be mentioned.
  • the sedative composition of the present invention is in the form of a detergent for textile products, the compound represented by the general formula (1) can be adhered to the textile product by washing the textile product, and the compound is adhered. Excellent sedation can be obtained through the use of textile products.
  • the sedation composition of the present invention is made into the form of a detergent for textile products, the sedation composition of the present invention includes a detergent for textile products in addition to the compound represented by the general formula (1). Other ingredients used in can be used.
  • a particularly suitable blending ratio of the compound represented by the general formula (1) is as follows: The proportion of the compound represented is 0.01 to 10% by weight, more preferably 0.05 to 5% by weight.
  • Examples of foods include health foods, foods for sick people, foods for specified health use, and dietary supplements.
  • the compound represented by the above general formula (1) is inhaled through the oral mucosa, staying in the mouth for a relatively long time, or tea. It is preferable that the compound represented by the general formula (1) volatilizes and is inhaled through the nasal mucosa before being put into the mouth, such as a flavoring agent.
  • Specific examples of such foods include gums, teas, beverages, rice cakes, flavorings, spices, gummi, yogurt, ice cream, edible films and the like.
  • the sedative composition of the present invention is selected from the compounds represented by the above general formula (1) that are acceptable for food hygiene. It is prepared by blending as a component of food.
  • the sedative composition of the present invention prepared in a food form is used as a sedative food or for sedation, to be used for promoting sleep, to be used for stress relief, Or it is useful as a food displayed to be used to improve sleep.
  • a particularly suitable blending ratio of the compound represented by the general formula (1) is represented by the general formula (1) in the composition.
  • the proportion of the compound is 0.01 to 10% by weight.
  • the sedative composition of the present invention includes, for example, bedding such as futons and pillows; clothing; curtains; doors; screen doors; interior materials; On the other hand, there are those used in a mode in which the compound represented by the general formula (1) is sprayed or applied.
  • the compound represented by the general formula (1) is volatilized from various articles to which the compound represented by the general formula (1) is adhered.
  • An excellent sedative effect can be obtained.
  • Preferred examples of such forms include spray preparations, aerosol preparations, liquid, jelly-like or cream-like preparations, and those obtained by impregnating them with a nonwoven fabric.
  • the invention's effect [0038]
  • the sedative composition of the present invention exhibits the same or similar scent as sandalwood and can exhibit an excellent mental sedative effect on humans and animals.
  • the sedative composition of the present invention also has an excellent sleep improving effect, fatigue recovery effect, stress relieving effect or relaxing effect. It is also useful as a fatigue recovery composition, a stress relaxation composition, or a relaxation composition. Among them, the sedative composition of the present invention is particularly useful as a sleep improving composition for inducing a good sleep state and inducing a good sleep state.
  • Example 1 and 3 and Comparative Examples 1 and 3 The compositions of Example 1-3 and Comparative Example 1-3 all have a sandalwood fragrance.
  • R 8 is methyl group
  • R 9 is hydrogen atom
  • A is
  • 1 ⁇ to 1 3 is methyl
  • R 8 is a methyl group
  • R 9 is a hydrogen atom
  • A is
  • Pentene-1-yl -4-penten-2-ol (general)
  • the subjects put a micromini R'R type actigraph (manufactured by AMI, USA; obtained from Christi Shoji Co., Ltd.) on their non-dominant arm at the time of going to bed, and measured and digitized the minute movements of the sleeping body. . Also, together with “Yuka Yamamoto et al., Development and standardization of OSA sleep questionnaire (MA version) for middle-aged and elderly, elderly people”, Brain and Psychiatry, 10th, 4th, 1999, In accordance with the method reported in Section 401-409, subjects were asked to make a judgment on each item of the OSA sleep schedule. Each factor of recovery and sleep time was evaluated.
  • FIGs. 1 to 3 show the results of the compositions of Examples 1 to 3, respectively;
  • Figures 4 to 6 show the results of the compositions of Comparative Examples 1 to 3, respectively.
  • A shows the amount of activity during sleep (average value of 5 subjects) (unit: actigraph count) measured by micromini R'R type actigraph; Shows the results of quantification of each factor of sleepiness at sleep, sleep onset and sleep maintenance, dream, recovery from fatigue, and sleep time based on the judgment results of each item of the OSA sleep questionnaire (average value of 5 subjects) Indicates.
  • a cosmetic product (cream) having the following composition was prepared according to a conventional method.
  • Carboxyvinyl polymer (trade name “Carbopol 980”, BF Goodrich) 0.20
  • 3-methyl-5- (2,2,3 A cosmetic (cream) was prepared with the same composition as in Example 4 except that -trimethyl-3-cyclopenten-1-yl) -pentane-2-ol was used.
  • 3-methyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -4-penten-2-ol 3-methyl-5- (2,2,3-trimethyl
  • a cosmetic (cream) was prepared with the same composition as in Example 4 except that -3-cyclopenten-1-yl) -pentane-2-ol was used.
  • Fig. 1 shows the results of evaluating the mental sedation effect and sleep improvement effect of the composition of Example 1 in Test Example 1.
  • A shows the amount of sleep activity (vertical axis; unit is the number of actigraph counts) measured by micromini R'R type actigraph;
  • B shows the judgment result of each item of the OSA sleep survey form Based on sleepiness, wakefulness, sleep and sleep maintenance, dream, fatigue The numerical results (vertical axis; judgment value) for each factor of recovery and sleep time are shown.
  • Test Example 1 the results of evaluating the mental sedation effect and sleep improvement effect of the composition of Example 2 are shown. Items displayed by A and B in the figure are the same as those in Figure 1.
  • Test Example 1 the results of evaluating the mental sedation effect and sleep improvement effect of the composition of Example 3 are shown. Items displayed by A and B in the figure are the same as those in Figure 1.

Abstract

[PROBLEMS] To provide a sedative composition which has an excellent sedative effect on the mind of a person or animal and a sleep-improving composition which can improve the sleep quality to induce good sleeping. [MEANS FOR SOLVING PROBLEMS] A sedative composition or sleep improving composition comprising a compound represented by the general formula (1): (1) wherein R1 to R7 independently represent a hydrogen atom, a hydroxyl group or a methyl group; R8 and R9 independently represent a hydrogen atom or a methyl group; A represents an ethylene or vinylene group; and n represents an integer of 0 to 10.

Description

明 細 書  Specification
鎮静用組成物  Sedative composition
技術分野  Technical field
[0001] 本発明は、鎮静用組成物に関する。より詳細には、人や動物の精神を鎮静させる 作用に優れて ヽる鎮静用組成物に関する。  [0001] The present invention relates to a sedative composition. More specifically, the present invention relates to a sedative composition that excels in the action of calming the spirit of humans and animals.
背景技術  Background art
[0002] ストレス等による精神的な悪影響を軽減し、精神を鎮静化する手段として、近年、各 種の植物由来の精油成分を利用したァロマセラピーが注目されている。特に、鎮静 作用を示す精油の中でも、サンダルウッド油は、睡眠を改善する作用に優れており、 鎮静用香料として有用であることが分力つている(例えば、特許文献 1及び 2参照)。  [0002] In recent years, aroma therapy using various plant-derived essential oil components has attracted attention as a means of reducing mental adverse effects due to stress and the like and calming the mind. In particular, among essential oils that exhibit a sedative effect, sandalwood oil is excellent in the effect of improving sleep and is useful as a sedative fragrance (see, for example, Patent Documents 1 and 2).
[0003] し力しながら、サンダルウッドは、近年、乱伐採によってその個体数が急激に減少し ており、該植物カゝら生産されるサンダルウッド油も減少の一途を迪つている。このよう なサンダルウッド油の生産量の減少に伴って、今日では、サンダルウッド油と同質の 香りを呈する合成化合物の開発が精力的に進められている。その一方、サンダルゥッ ド油による鎮静作用は、嗅知されるサンダルウッド油の香りとは直接的な因果関係が ないことが分力 ており、サンダルウッドと同質又は近似する香りを呈する化合物であ つてもその鎮静作用の存否については全く類推できるものではない。そのため、サン ダルウッドと同質又は近似する香りを呈する合成化合物の内、どのような構造の化合 物を選択し使用すれば鎮静効果や睡眠改善効果が得られるかについては、全く分 かって!/ヽな ヽのが現状である。  [0003] However, sandalwood has been rapidly decreasing in number in recent years due to overcutting, and sandalwood oil produced from the plant moss has been steadily decreasing. With such a decrease in the production of sandalwood oil, the development of synthetic compounds exhibiting the same scent as sandalwood oil is being energetically promoted today. On the other hand, the sedative effect of sandalwood oil has no direct causal relationship with the smell of smelled sandalwood oil, and it is a compound that exhibits the same or similar scent as sandalwood. However, there is no analogy about the presence or absence of the sedative effect. For this reason, it is quite clear what kind of structure of a synthetic compound that has the same or similar scent as sandalwood can be used to obtain a sedative effect or sleep improvement effect! The current situation is Tatsuno.
特許文献 1:特開平 7— 316582号公報  Patent Document 1: Japanese Patent Laid-Open No. 7-316582
特許文献 2:特公平 7— 57734号公報  Patent Document 2: Japanese Patent Publication No. 7-57734
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明の目的は、人や動物の精神を鎮静させる作用に優れて 、る鎮静用組成物 を提供することである。 [0004] An object of the present invention is to provide a composition for sedation which is excellent in the action of sedating a human or animal spirit.
課題を解決するための手段 [0005] 本発明者らは、上記課題を解決すべく鋭意検討したところ、下記の一般式 (1)で表 される化合物は、サンダルウッドと同質又は近似する香りを呈すると共に、精神を鎮 静する作用や、安眠を誘発する作用に優れていることを見出した。本発明はかかる 知見に基づいて、更に検討を重ねて開発されたものである。 Means for solving the problem [0005] The present inventors diligently studied to solve the above-mentioned problems. As a result, the compound represented by the following general formula (1) exhibits a scent that is the same as or close to that of sandalwood and calms the mind. It was found to be excellent in the action of inducing sleepiness and inducing sleep. The present invention has been developed through further studies based on such knowledge.
[0006] 即ち、本発明は、下記に掲げる発明を提供するものである:  That is, the present invention provides the following inventions:
項 1. 一般式 (1)で表される化合物  Item 1. Compound represented by general formula (1)
[0007] [化 1]  [0007] [Chemical 1]
Figure imgf000004_0001
Figure imgf000004_0001
[0008] [式中、 R〜Rは、同一又は異なって、水素原子、水酸基又はメチル基を示し、 R [Wherein, R to R are the same or different and each represents a hydrogen atom, a hydroxyl group or a methyl group;
8及び R  8 and R
9は、同一又は異なって、水素原子又はメチル基を示し、 9 is the same or different and represents a hydrogen atom or a methyl group;
Aは、エチレン基又はビ-レン基を示し、 nは、 0〜 10の整数を示す] A represents an ethylene group or a beylene group, and n represents an integer of 0 to 10]
を含有することを特徴とする、鎮静用組成物。  A sedative composition comprising: a sedative composition.
項 2. —般式 (1)において、 R〜Rの内、少なくとも 3つカ^チル基である、項 1に記 載の鎮静用組成物。  Item 2. —The composition for sedation according to Item 1, wherein in General Formula (1), at least three of R to R are acetyl groups.
項 3. —般式 (1)において、 R〜Rが全てメチル基であって R〜Rが全て水素原子  Item 3. — In the general formula (1), R to R are all methyl groups, and R to R are all hydrogen atoms.
1 3 4 7  1 3 4 7
である、項 1に記載の鎮静用組成物。  Item 2. The sedative composition according to Item 1.
項 4. 一般式 (1)において、 R及び Rの内、何れか一方又は双方カ チル基である  Item 4. In the general formula (1), either one or both of R and R are acetyl groups.
8 9  8 9
、項 1に記載の鎮静用組成物。  Item 2. A sedative composition according to Item 1.
項 5. —般式 (1)において、 nが 0〜2である、項 1に記載の鎮静用組成物。  Item 5. —The sedative composition according to Item 1, wherein n is 0 to 2 in the general formula (1).
項 6. —般式 (1)において、 R〜Rが全てメチル基であり、 R〜Rが全て水素原子  Item 6. — In general formula (1), R to R are all methyl groups, and R to R are all hydrogen atoms.
1 3 4 7  1 3 4 7
であり、 R及び Rの内、何れか一方又は双方カ チル基である、項 1に記載の鎮静  Item 2. The sedation according to Item 1, wherein one or both of R and R are acetyl groups.
8 9  8 9
用組成物。  Composition.
項 7. —般式 (1)で表される化合物が、  Item 7. —The compound represented by the general formula (1) is
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがェチレ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、 R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがビ-レA compound wherein n is 0, R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、又は  A group wherein n is 0, or
R〜R力 Sメチル基、 R〜Rが水素原子、 R及び R力 Sメチル基、 Aがビ-レン基で、 R ~ R force S methyl group, R ~ R is hydrogen atom, R and R force S methyl group, A is beylene group,
1 3 4 7 8 9 1 3 4 7 8 9
nが 0である化合物  n is 0
である、項 1に記載の鎮静用組成物。  Item 2. The sedative composition according to Item 1.
項 8. 鎮静用組成物中で、一般式 (1)で表される化合物及び香料成分の総量に対し て、一般式 (1)で表される化合物が占める割合が 10重量%以上である、項 1乃至 7の Vヽずれかに記載の鎮静用組成物。  Item 8. In the sedative composition, the ratio of the compound represented by the general formula (1) to the total amount of the compound represented by the general formula (1) and the fragrance component is 10% by weight or more. Item 8. A sedative composition according to any one of items 1 to 7,
項 9. 芳香剤、香粧品、吸入投与剤、繊維製品用洗剤、又は食品の形態である、項 1乃至 8のいずれか〖こ記載の鎮静用組成物。  Item 9. The sedative composition according to any one of Items 1 to 8, which is in the form of a fragrance, a cosmetic, an inhalation agent, a textile detergent, or a food.
項 10. —般式 (1)で表される化合物  Item 10. —Compound represented by formula (1)
[0009] [化 2] [0009] [Chemical 2]
Figure imgf000005_0001
Figure imgf000005_0001
[0010] [式中、 R〜Rは、同一又は異なって、水素原子、水酸基又はメチル基を示し、[Wherein R to R are the same or different and each represents a hydrogen atom, a hydroxyl group or a methyl group,
R及び Rは、同一又は異なって、水素原子又はメチル基を示し、 R and R are the same or different and each represents a hydrogen atom or a methyl group,
8 9  8 9
Aは、エチレン基又はビ-レン基を示し、  A represents an ethylene group or a beylene group,
nは、 0〜 10の整数を示す]  n represents an integer of 0 to 10]
を含有することを特徴とする、睡眠改善用組成物。  A composition for improving sleep, comprising:
項 11. 一般式 (1)において、 R〜Rの内、少なくとも 3つがメチル基である、項 10に 記載の睡眠改善用組成物。  Item 11. The sleep improving composition according to Item 10, wherein, in General Formula (1), at least three of R to R are methyl groups.
項 12. —般式 (1)において、 R〜Rが全てメチル基であって R〜Rが全て水素原  Item 12. —In the general formula (1), R to R are all methyl groups, and R to R are all hydrogen atoms.
1 3 4 7  1 3 4 7
子である、項 10に記載の睡眠改善用組成物。  Item 11. The composition for improving sleep according to Item 10, which is a child.
項 13. —般式 (1)において、 R及び Rの内、何れか一方又は双方カ チル基であ  Item 13. —In the general formula (1), either one or both of R and R are acetyl groups.
8 9  8 9
る、項 10に記載の睡眠改善用組成物。  Item 11. The composition for improving sleep according to Item 10.
項 14. 一般式 (1)において、 n力^〜 2である、項 10に記載の睡眠改善用組成物。 項 15. —般式 (1)において、 R〜Rが全てメチル基であり、 R〜Rが全て水素原子 Item 14. The composition for improving sleep according to Item 10, wherein n force ^ -2 in the general formula (1). Item 15. —In the general formula (1), R to R are all methyl groups, and R to R are all hydrogen atoms.
1 3 4 7  1 3 4 7
であり、 R及び Rの内、何れか一方又は双方カ チル基である、項 10に記載の睡眠  The sleep according to Item 10, wherein any one or both of R and R are acetyl groups.
8 9  8 9
改善用組成物。  Composition for improvement.
項 16. —般式 (1)で表される化合物が、  Item 16. —The compound represented by the general formula (1) is
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがェチレ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、  A compound wherein n is 0,
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがビ-レ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、又は  A group wherein n is 0, or
R〜R力 Sメチル基、 R〜Rが水素原子、 R及び R力 Sメチル基、 Aがビ-レン基で、 R ~ R force S methyl group, R ~ R is hydrogen atom, R and R force S methyl group, A is beylene group,
1 3 4 7 8 9 1 3 4 7 8 9
nが 0である化合物  n is 0
である、項 10に記載の睡眠改善用組成物。  Item 11. The composition for improving sleep according to Item 10, wherein
項 17. 睡眠改善用組成物中で、一般式 (1)で表される化合物及び香料成分の総量 に対して、一般式 (1)で表される化合物が占める割合が 10重量%以上である、項 10 乃至 16のいずれかに記載の睡眠改善用組成物。  Item 17. In the composition for improving sleep, the ratio of the compound represented by the general formula (1) to the total amount of the compound represented by the general formula (1) and the fragrance component is 10% by weight or more. Item 17. The composition for improving sleep according to any one of Items 10 to 16.
項 18. 芳香剤、香粧品、吸入投与剤、繊維製品用洗剤、又は食品の形態である、 項 10乃至 17のいずれかに記載の睡眠改善用組成物。  Item 18. The sleep improving composition according to any one of Items 10 to 17, which is in the form of a fragrance, a cosmetic, an inhalation agent, a textile detergent, or a food.
[0011] 以下に、本発明を詳細に説明する。本発明において、「鎮静用組成物」とは、人や 動物の精神を鎮静させることにより、リラックスさせ、又は睡眠を改善させるために使 用されるものである。また、本発明において、「睡眠改善用組成物」とは、起床時の眠 気を改善する、入眠をスムーズにする、中途覚醒を減らす、等の作用によって、安眠 を誘発して良好な睡眠状態を導くために使用されるものである。  [0011] Hereinafter, the present invention will be described in detail. In the present invention, the “sedative composition” is used to relax or improve sleep by soothing the mind of a human or animal. In the present invention, the “sleep improvement composition” refers to a good sleep state that induces sleep by improving sleepiness when waking up, smoothing sleep, reducing arousal during sleep, etc. Is used to guide
[0012] 本発明の鎮静用組成物は、下記一般式 (1)の化合物を含有することを特徴とするも のである。  [0012] The sedative composition of the present invention is characterized by containing a compound of the following general formula (1).
[0013] [化 3]  [0013] [Chemical 3]
Figure imgf000006_0001
[0014] 式中、 I^〜R7は、同一又は異なって、水素原子、水酸基又はメチル基であり、好ま しくは水素原子又はメチル基である。一般式 (1)の化合物において、 R〜Rの内、少 なくとも 3つカ^チル基であることが好ましぐ特に R メチル基であって R
Figure imgf000006_0001
In the formula, I ^ to R 7 are the same or different and are a hydrogen atom, a hydroxyl group or a methyl group, preferably a hydrogen atom or a methyl group. In the compound of the general formula (1), at least three of R to R are preferably acetyl groups, particularly R methyl group and R
1〜Rが全て 1 ~ R are all
3 4 3 4
〜Rが全て水素原子であることが好ましい。 All of ~ R are preferably hydrogen atoms.
[0015] また、式中、 R及び Rは、同一又は異なって、水素原子又はメチル基である。一般 [0015] In the formula, R and R are the same or different and each represents a hydrogen atom or a methyl group. General
8 9  8 9
式 (1)の化合物において、 R及び Rの内、何れか一方又は双方力 Sメチル基であること  In the compound of the formula (1), either one or both of R and R are S methyl groups.
8 9  8 9
が望ましい。  Is desirable.
[0016] 式中、 Aは、エチレン基(CH2— CH2)又はビ-レン基(CH = CH)である。  In the formula, A represents an ethylene group (CH 2 —CH 2) or a beylene group (CH═CH).
[0017] また、式中、 nは 0〜10の整数である。一般式 (1)の化合物において、好ましくは nが[0017] In the formula, n is an integer of 0 to 10. In the compound of the general formula (1), preferably n is
0〜2であり、更に好ましくは nが 0又は 1であり、特に好ましくは nが 0である。 0 to 2, more preferably n is 0 or 1, and particularly preferably n is 0.
[0018] 本発明に使用される一般式 (1)の化合物の内、好適な化合物の具体例として、[0018] Among the compounds of the general formula (1) used in the present invention, as specific examples of suitable compounds,
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 AがェチレR ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、及び nが 0である化合物(即ち、 3-メチル -5- (2,2,3-トリメチル -3-シクロペンテン -1-ィル) -ペンタン- 2-オール);  And a compound in which n is 0 (ie, 3-methyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -pentan-2-ol);
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがビ-レ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、及び nが 0である化合物(即ち、 3-メチル -5- (2,2,3-トリメチル -3-シクロペンテン -1-ィル) -4-ペンテン- 2-オール);及び  And a compound in which n is 0 (ie 3-methyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -4-penten-2-ol);
R〜R力 Sメチル基、 R〜Rが水素原子、 R及び R力 Sメチル基、 Aがビ-レン基、及 R ~ R force S methyl group, R ~ R is hydrogen atom, R and R force S methyl group, A is beylene group, and
1 3 4 7 8 9 1 3 4 7 8 9
び n力 ^である化合物(即ち、 3,3-ジメチル- 5-(2,2,3-トリメチル - 3-シクロペンテン- 1- ィル) -4-ペンテン- 2-オール)  A compound that has n force ^ (ie 3,3-dimethyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -4-penten-2-ol)
が例示される。  Is exemplified.
[0019] 上記一般式 (1)で表される化合物は、公知化合物、又は公知化合物力 容易に誘 導される化合物である。一般式 (1)で表される化合物は、基本骨格や置換基の種類 等に応じて、種々の公知の合成方法により製造される。  The compound represented by the general formula (1) is a known compound or a compound that is easily derived from a known compound power. The compound represented by the general formula (1) is produced by various known synthetic methods depending on the basic skeleton, the type of substituents, and the like.
[0020] 例えば、一般式 (1)で表される化合物は、下記一般式 (2)で表される化合物(式中、 R  [0020] For example, the compound represented by the general formula (1) is a compound represented by the following general formula (2) (wherein R
〜R及び nは前記と同じ)と、適当なアルデヒド又はケトンとを適当な条件でアルド一 ル縮合させ、更に適当な条件で還元することによって得ることができる。  ~ R and n are the same as described above) and an appropriate aldehyde or ketone is subjected to aldol condensation under appropriate conditions, and further reduced under appropriate conditions.
[0021] [化 4]
Figure imgf000008_0001
[0021] [Chemical 4]
Figure imgf000008_0001
[0022] また、一般式 (1)で表される化合物の原料ィ匕合物として使用される一般式 (2)で表さ れる化合物は、公知化合物又は公知化合物から容易に誘導される化合物である。例 えば、一般式 (2)で表される化合物がカンフオレナール(campholenicaldehyde;—般式 (2)中、 R〜R力 Sメチル基、 R〜Rが水素原子、 n力 SOである化合物)の場合であれ [0022] Further, the compound represented by the general formula (2) used as the raw material mixture of the compound represented by the general formula (1) is a known compound or a compound easily derived from the known compound. is there. For example, the compound represented by the general formula (2) is camphorolenal (campholenicaldehyde; a compound in which R to R force S methyl group, R to R is hydrogen atom, n force SO in general formula (2)) Even if
1 3 4 6 1 3 4 6
ば、 a ピネン( α -pinene)をエポキシ化し、得られたェポキサイドを ZnBr存在下で 適当な条件で反応させることにより得ることができる。  For example, a pinene (α-pinene) can be epoxidized, and the resulting epoxide can be reacted in the presence of ZnBr under appropriate conditions.
[0023] 本発明の鎮静用組成物において、上記一般式 (1)で表される化合物として、 1種の 化合物を単独で使用してもよぐまた 2種以上の化合物を任意に組み合わせて使用 してちよい。 [0023] In the sedative composition of the present invention, as the compound represented by the general formula (1), one compound may be used alone, or two or more compounds may be used in any combination. You can do it.
[0024] 上記一般式 (1)で表される化合物には、それ自体サンダルウッド系の芳香を呈する ものも含まれる。本発明の鎮静用組成物には、上記一般式 (1)で表される化合物以外 に、天然の植物及び動物より既存の抽出方法により得られる精油成分や合成香料等 の香気を呈する成分 (以下、「香料成分」と表記する)が含有されていても良い。但し 、このような場合、本発明の鎮静用組成物において、上記一般式 (1)で表される化合 物と香料成分 (一般式 (1)で表される化合物以外の香料成分)の合計量に対して、上 記一般式 (1)で表される化合物が 10重量%以上、好ましくは 40重量%以上、更に好 ましくは 70重量%以上であることが望ましい。このような割合で上記一般式 (1)で表さ れる化合物を使用することによって、本発明の効果を顕著ならしめることができる。  [0024] The compound represented by the general formula (1) includes a compound that itself exhibits a sandalwood fragrance. In the sedation composition of the present invention, in addition to the compound represented by the general formula (1), a component exhibiting aroma such as an essential oil component or a synthetic fragrance obtained from natural plants and animals by an existing extraction method (hereinafter referred to as a fragrance composition) , "Denoted as" perfume ingredient "). However, in such a case, in the sedation composition of the present invention, the total amount of the compound represented by the general formula (1) and the fragrance component (fragrance components other than the compound represented by the general formula (1)). On the other hand, the compound represented by the general formula (1) is preferably 10% by weight or more, preferably 40% by weight or more, and more preferably 70% by weight or more. By using the compound represented by the general formula (1) at such a ratio, the effects of the present invention can be made remarkable.
[0025] 本発明の鎮静用組成物は、上記一般式 (1)で表される化合物のみカゝら構成されて いてもよいが、使用形態に応じて、担体、基材又は添加物等の他の成分を含有して いてもよい。本発明の鎮静用組成物において、上記一般式 (1)で表される化合物の配 合割合としては、該組成物の使用形態、期待される効果の程度、使用者の性別や年 齢等によって異なるが、一例として、該組成物の総重量に対して、一般式 (1)で表され る化合物が 0. 01〜: L00重量%、好ましくは 0. 05〜80重量%となる割合が挙げられ る。 [0025] The sedative composition of the present invention may be composed of only the compound represented by the general formula (1), but depending on the form of use, it may be a carrier, a substrate, an additive, or the like. Other components may be contained. In the sedation composition of the present invention, the ratio of the compound represented by the general formula (1) depends on the use form of the composition, the degree of expected effect, the gender and age of the user, etc. Although different, for example, the ratio of the compound represented by the general formula (1) to 0.01 to L00% by weight, preferably 0.05 to 80% by weight, with respect to the total weight of the composition. Is The
[0026] 本発明の鎮静用組成物は、上記一般式 (1)で表される化合物が吸入又は吸収され るように調製されている限り、その形態については特に制限されない。本発明の鎮静 用組成物の形態として、具体例には、芳香剤、香粧品、吸入投与剤、繊維製品用洗 剤、食品等が挙げられる。好ましくは、芳香剤、香粧品、吸入投与剤、繊維製品用洗 剤であり、更に好ましくは、芳香剤、香粧品である。  [0026] The form of the sedative composition of the present invention is not particularly limited as long as the compound represented by the general formula (1) is prepared so as to be inhaled or absorbed. Specific examples of the form of the sedative composition of the present invention include fragrances, cosmetics, inhalation administration agents, textile detergents, foods and the like. Preferred are fragrances, cosmetics, inhalation administration agents, and textile products, and more preferred are fragrances and cosmetics.
[0027] 芳香剤としては、例えば、寝室用、リビング用、トイレ用、玄関用、浴室用、クローゼ ット用、タンス用等の従来力も芳香剤として使用されているものが挙げられる。芳香剤 の形態についても、制限されるものではなぐ固体状、半固体状 (ゼリー状、ゲル状等 )、液体状、エアゾール状等の様々な形態が使用される。また、当該芳香剤は、上記 一般式 (1)で表される化合物を自然蒸散させることにより使用してもよぐまた該化合 物を加熱により蒸散させてもよい。特に、上記一般式 (1)で表される化合物が揮発性 に乏し 、場合には、加熱により蒸散させることが望ま 、。  [0027] Examples of the fragrances include those for which conventional power is also used as fragrances, such as for bedrooms, living rooms, toilets, entrances, bathrooms, closets, and chiffons. The form of the fragrance is not limited, and various forms such as a solid form, a semi-solid form (jelly form, gel form, etc.), a liquid form, and an aerosol form are used. In addition, the fragrance may be used by spontaneously evaporating the compound represented by the general formula (1), or the compound may be evaporated by heating. In particular, if the compound represented by the general formula (1) is poor in volatility, it is desirable to evaporate by heating.
[0028] 本発明の鎮静用組成物を芳香剤の形態にする場合、本発明の鎮静用組成物には 、上記一般式 (1)で表される化合物に加えて、従来芳香剤に使用されてきた基剤、担 体、添加剤等の成分を含有させることができる。芳香剤に配合される基剤としては、 例えば、水、エタノール、固体又は液体の陰イオン性、陽イオン性、非イオン性活性 剤、高分子剤、油脂、グァガム、キサンタンガム、アラビアガム、ジエランガム、カラギ 一ナン、ゼラチン、寒天、非水溶性溶剤、ろう、ワセリン、ラノリン等が挙げられる。  [0028] When the sedative composition of the present invention is used in the form of a fragrance, the sedative composition of the present invention is conventionally used as a fragrance in addition to the compound represented by the general formula (1). Ingredients such as the base, support, additive, etc., can be contained. Examples of the base compounded in the fragrance include water, ethanol, solid or liquid anionic, cationic, nonionic active agent, polymer agent, fats and oils, guar gum, xanthan gum, gum arabic, and dielan gum. Carrageenan, gelatin, agar, water-insoluble solvent, wax, petrolatum, lanolin and the like.
[0029] 本発明の鎮静用組成物を芳香剤形態にする場合、一般式 (1)で表される化合物の 特に好適な配合割合としては、該組成物中に一般式(1)で表される化合物が 5〜80 重量%、更に好ましくは 40〜60重量%となる割合が挙げられる。  [0029] When the sedative composition of the present invention is in the form of a fragrance, a particularly suitable blending ratio of the compound represented by the general formula (1) is represented by the general formula (1) in the composition. The proportion of the compound is 5 to 80% by weight, more preferably 40 to 60% by weight.
[0030] 香粧品には、化粧料に加えて、石鹼等の生体洗浄剤、入浴剤等も包含される。香 粧品の具体例としては、クリーム、乳液、化粧パウダー、ボディーローション、整髪料、 洗髪料、石鹼、ボディーソープ、制汗剤、シャンプー、リンス、香水、化粧水、練歯磨 、液体歯磨、洗口剤、マウスペット、サンスクリーン、台所用洗剤、マッサージオイル、 マッサージクリーム、スキンケアオイル、等が例示される。本発明の鎮静用組成物を 香粧品の形態にする場合、本発明の鎮静用組成物には、上記一般式 (1)で表される 化合物に加えて、従来香粧品に使用されてきた基剤や添加剤等の成分を含有させ ることができる。基剤としては、特に制限されないが、例えば、水、エタノール、タルク 、ゼラチン、ろう、ワセリン、ラノリン等が挙げられる。添加剤としては、特に制限されな いが、例えば、保湿剤、皮膚柔軟剤、防腐剤、溶解剤、香料等が挙げられる。 [0030] In addition to cosmetics, cosmetics include biological cleaning agents such as sarcophagus, bathing agents, and the like. Specific examples of cosmetics include creams, milky lotions, cosmetic powders, body lotions, hair styling, hair shampoos, sarcophagus, body soaps, antiperspirants, shampoos, rinses, perfumes, lotions, toothpastes, liquid toothpastes, washing Examples include mouth preparations, mouse pets, sunscreens, kitchen detergents, massage oils, massage creams, skin care oils, and the like. When the sedative composition of the present invention is made into a cosmetic product, the sedative composition of the present invention is represented by the general formula (1). In addition to the compound, components such as bases and additives conventionally used in cosmetics can be contained. The base is not particularly limited, and examples thereof include water, ethanol, talc, gelatin, wax, petrolatum, and lanolin. The additive is not particularly limited, and examples thereof include humectants, skin softeners, preservatives, solubilizers, and fragrances.
[0031] 本発明の鎮静用組成物を芳香剤形態にする場合、一般式 (1)で表される化合物の 特に好適な配合割合としては、該組成物中に一般式(1)で表される化合物が 0. 01 〜50重量%、更に好ましくは 0. 05〜10重量%、より好ましくは 0. 1〜1重量%とな る割合が挙げられる。  [0031] When the sedative composition of the present invention is in the form of a fragrance, a particularly suitable blending ratio of the compound represented by the general formula (1) is represented by the general formula (1) in the composition. The proportion of the compound is 0.01 to 50% by weight, more preferably 0.05 to 10% by weight, and still more preferably 0.1 to 1% by weight.
[0032] 吸入投与剤とは、上記一般式 (1)で表される化合物を鼻付近で揮散又は鼻腔に適 用させて意図的に該化合物を吸入させる製剤のことであり、その具体例としては点鼻 薬、噴霧剤、吸入液、該化合物を担持させたマスク等が挙げられる。本発明の鎮静 用組成物を吸入投与剤の形態にする場合、本発明の鎮静用組成物には、上記一般 式 (1)で表される化合物に加えて、従来吸入投与剤に使用されてきた基剤や添加剤 等の成分を含有させることができる。また、吸入用の気体を使用する場合も従来の吸 入投与剤に使用されてきた気体を使用することができる。当該吸入投与剤の投与は [0032] An inhalation administration agent is a preparation in which the compound represented by the above general formula (1) is volatilized in the vicinity of the nose or applied to the nasal cavity to intentionally inhale the compound. Examples include nasal sprays, sprays, inhalation solutions, and masks carrying the compounds. When the sedation composition of the present invention is in the form of an inhalation administration agent, the sedation composition of the present invention has been conventionally used for an inhalation administration agent in addition to the compound represented by the general formula (1). Ingredients such as bases and additives can be included. In addition, when an inhalation gas is used, the gas that has been used in conventional inhalation administration agents can be used. Administration of the inhalation agent
、特に制限されないが、 1回当たり 5〜60秒で 1日当たり 1〜10回程度行なうのが好 ましい。また制限されないが、当該吸入投与剤は、使用時に、吸入される気体中に上 記一般式 (1)で表される化合物力 通常 0.000001ppm〜10ppm、好ましくは O.OOOOlpp m〜0.1ppm、更に好ましくは 0.0001ppm〜0.001ppm程度の濃度で揮散するように適 宜設定しておくことが望ましい。 Although not particularly limited, it is preferable to perform 1 to 10 times per day in 5 to 60 seconds per time. Although not limited, the inhalation administration agent is a compound power represented by the above general formula (1) in the inhaled gas at the time of use, usually 0.000001 ppm to 10 ppm, preferably O.OOOOlppm to 0.1 ppm, It is desirable to set appropriately so as to volatilize at a concentration of about 0.0001 ppm to 0.001 ppm.
[0033] 繊維製品用洗剤としては、例えば、陰イオン性、陽イオン性、非イオン性若しくは両 性イオン性の洗剤、繊維製品柔軟剤、繊維製品柔軟用製品、ドライヤー用繊維柔軟 剤製品等が挙げられる。本発明の鎮静用組成物が繊維製品用洗剤の形態の場合、 繊維製品の洗浄によって、上記一般式 (1)で表される化合物を繊維製品に付着させ ることができ、該化合物が付着した繊維製品の使用を通して優れた鎮静作用を得る ことができる。本発明の鎮静用組成物を繊維製品用洗剤の形態にする場合、本発明 の鎮静用組成物には、上記一般式 (1)で表される化合物に加えて、従来から繊維製 品用洗剤に使用されている他の成分を使用することができる。 [0034] 本発明の鎮静用組成物を繊維製品用洗剤形態にする場合、一般式 (1)で表され る化合物の特に好適な配合割合としては、該組成物中に一般式(1)で表される化合 物が 0. 01〜10重量%、更に好ましくは 0. 05〜5重量%となる割合が挙げられる。 [0033] Examples of textile detergents include anionic, cationic, nonionic or zwitterionic detergents, textile softeners, textile softeners, dryer textile softeners, and the like. Can be mentioned. When the sedative composition of the present invention is in the form of a detergent for textile products, the compound represented by the general formula (1) can be adhered to the textile product by washing the textile product, and the compound is adhered. Excellent sedation can be obtained through the use of textile products. When the sedation composition of the present invention is made into the form of a detergent for textile products, the sedation composition of the present invention includes a detergent for textile products in addition to the compound represented by the general formula (1). Other ingredients used in can be used. [0034] When the sedative composition of the present invention is made into a detergent for textile products, a particularly suitable blending ratio of the compound represented by the general formula (1) is as follows: The proportion of the compound represented is 0.01 to 10% by weight, more preferably 0.05 to 5% by weight.
[0035] 食品としては、例えば、健康食品、病者用食品、特定保健用食品、栄養補助食品 等が挙げられる。特に制限されないが、鎮静効果を効率よく得るためには、口中に比 較的長い時間留まり口腔粘膜を経由して上記一般式 (1)で表される化合物が吸入さ れる形態のものや、茶、着香料等のように口に入れる前に上記一般式 (1)で表される 化合物が揮散して鼻腔粘膜を経由して吸入されるものが好ましい。このような食品と して、具体的には、ガム、茶、飲料、飴、着香料、香辛料、グミ、ヨーグルト、アイスタリ ーム、可食フィルム等が挙げられる。本発明の鎮静用組成物を食品の形態にする場 合、本発明の鎮静用組成物は、上記一般式 (1)で表される化合物の内、食品衛生上 許容されるものを選択して、食品の一成分として配合することにより調製される。食品 形態に調製された本発明の鎮静用組成物は、鎮静用食品として、或いは鎮静のため に使用される旨、安眠促進のために使用される旨、ストレス緩和のために使用される 旨、又は睡眠を改善するために使用される旨が表示された食品として有用である。  [0035] Examples of foods include health foods, foods for sick people, foods for specified health use, and dietary supplements. Although not particularly limited, in order to obtain a sedative effect efficiently, the compound represented by the above general formula (1) is inhaled through the oral mucosa, staying in the mouth for a relatively long time, or tea. It is preferable that the compound represented by the general formula (1) volatilizes and is inhaled through the nasal mucosa before being put into the mouth, such as a flavoring agent. Specific examples of such foods include gums, teas, beverages, rice cakes, flavorings, spices, gummi, yogurt, ice cream, edible films and the like. When the sedative composition of the present invention is in the form of food, the sedative composition of the present invention is selected from the compounds represented by the above general formula (1) that are acceptable for food hygiene. It is prepared by blending as a component of food. The sedative composition of the present invention prepared in a food form is used as a sedative food or for sedation, to be used for promoting sleep, to be used for stress relief, Or it is useful as a food displayed to be used to improve sleep.
[0036] 本発明の鎮静用組成物を食品形態にする場合、一般式(1)で表される化合物の特 に好適な配合割合としては、該組成物中に一般式(1)で表される化合物が 0. 01〜 10重量%なる割合が挙げられる。  [0036] When the sedative composition of the present invention is made into a food form, a particularly suitable blending ratio of the compound represented by the general formula (1) is represented by the general formula (1) in the composition. The proportion of the compound is 0.01 to 10% by weight.
[0037] 上記の他に、本発明の鎮静用組成物の形態として、例えば、布団、枕等の寝具;衣 類;カーテン;ドア;網戸;内装材;ソファー等の生活用品や、ペット用品等に対して、 上記一般式 (1)で表される化合物を噴霧又は塗布させる態様で使用されるものが挙 げられる。  [0037] In addition to the above, the sedative composition of the present invention includes, for example, bedding such as futons and pillows; clothing; curtains; doors; screen doors; interior materials; On the other hand, there are those used in a mode in which the compound represented by the general formula (1) is sprayed or applied.
力かる形態の鎮静用組成物を使用することにより、上記一般式 (1)で表される化合物 が付着した各種用品から上記一般式 (1)で表される化合物が揮散され、これによつて 優れた鎮静効果を得ることができる。このような形態のものとして、好適には、スプレ 一製剤、エアゾール製剤、液状、ジエル状又はクリーム状の製剤、またそれらを不織 布等に含浸させたもの等が例示される。  By using a powerful sedative composition, the compound represented by the general formula (1) is volatilized from various articles to which the compound represented by the general formula (1) is adhered. An excellent sedative effect can be obtained. Preferred examples of such forms include spray preparations, aerosol preparations, liquid, jelly-like or cream-like preparations, and those obtained by impregnating them with a nonwoven fabric.
発明の効果 [0038] 本発明の鎮静用組成物は、サンダルウッドと同質又は近似する香りを呈すると共に 、人や動物に対して優れた精神鎮静作用を発揮することができる。 The invention's effect [0038] The sedative composition of the present invention exhibits the same or similar scent as sandalwood and can exhibit an excellent mental sedative effect on humans and animals.
[0039] また、本発明の鎮静用組成物は、優れた鎮静作用に加え、優れた睡眠改善作用、 疲労回復作用、ストレス緩和作用又はリラックス作用をも有しているので、睡眠改善用 組成物、疲労回復用組成物、ストレス緩和用組成物又はリラックス用組成物としても 有用である。中でも特に、本発明の鎮静用組成物は、安眠を誘発して良好な睡眠状 態を導くための睡眠改善用組成物として有用である。  [0039] In addition to the excellent sedative effect, the sedative composition of the present invention also has an excellent sleep improving effect, fatigue recovery effect, stress relieving effect or relaxing effect. It is also useful as a fatigue recovery composition, a stress relaxation composition, or a relaxation composition. Among them, the sedative composition of the present invention is particularly useful as a sleep improving composition for inducing a good sleep state and inducing a good sleep state.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0040] 以下、実施例を挙げて本発明を説明するが、本発明はこれらの実施例に限定され るものではない。 Hereinafter, the present invention will be described with reference to examples, but the present invention is not limited to these examples.
麵 I  麵 I
軽度の不眠を自覚している健常成人 5名(男性 3名、女性 2名)を被験者として、表 1 に示す組成物(実施例 1 3及び比較例 1 3)の鎮静作用の評価試験を、以下の方 法に従って実施した。実施例 1—3及び比較例 1—3の組成物は、いずれもサンダル ウッド系の芳香を呈するものである。  Using 5 healthy adults (3 males and 2 females) who are aware of mild insomnia as subjects, the evaluation test of the sedative effect of the compositions shown in Table 1 (Examples 1 and 3 and Comparative Examples 1 and 3) The following method was used. The compositions of Example 1-3 and Comparative Example 1-3 all have a sandalwood fragrance.
[0041] [表 1] [0041] [Table 1]
実施例 比較例 配合成分 Examples Comparative Examples Ingredients
1 2 3 1 2 3 1 2 3 1 2 3
3-メチル - 5-(2,2,3-トリメチル -3-シクロペン 3-Methyl-5- (2,2,3-trimethyl-3-cyclopent
テン-卜ィル) -ペンタン- 2-オール(一般式(1)に  Ten-zyl) -pentane-2-ol (in general formula (1)
おいて、 1^〜1¾3がメチル基、 R4〜R7が水素 1 ^ to 1¾ 3 are methyl groups, R 4 to R 7 are hydrogen
50  50
原子、 R8がメチル基、 R9が水素原子、 Aがェ Atom, R 8 is methyl group, R 9 is hydrogen atom, A is
チレン基、 及び nが 0である化合物) :商品名  Tylene group and a compound in which n is 0): Trade name
「Sandalore」、 Givaduan- Roure社製  "Sandalore", manufactured by Givaduan-Roure
3-メチル -5- (2,2,3-トリメチル -3-シクロペン  3-methyl-5- (2,2,3-trimethyl-3-cyclopent
テン- 1-ィル) -4-ペンテン- 2-オール(一般式(1)  Ten-1-yl) -4-penten-2-ol (general formula (1)
において、 1^〜1 3がメチル基、 R4~R7が水 - 50 - - - 素原子、 R8がメチル基、 R 9が水素原子、 Aが In, 1 ^ to 1 3 is methyl, R 4 ~ R 7 water - 50 - - - atom, R 8 is a methyl group, R 9 is a hydrogen atom, A is
芳 ピニレン基、 及び nが 0である化合物):商品名  Yoshi Pinylene group and n is 0)
「Ebanol」、 Givaduan - Roure ft製  "Ebanol", made by Givaduan-Roure ft
3,3-ジメチル-5-(2,2,3-トリメチル- 3-シクロ  3,3-dimethyl-5- (2,2,3-trimethyl-3-cyclo
化 ペンテン- 1-ィル) -4-ペンテン- 2-オール (一般  Pentene-1-yl) -4-penten-2-ol (general)
式(1)において、 1^〜1 3がメチル基、 R4〜R 一 - 50 ― ― ― 7が水素原子、 R8及び R9がメチル基、 Aがビ In the formula (1), 1 ^ to 1 3 is methyl, R 4 to R one - 50 - - - 7 are hydrogen atoms, R 8 and R 9 are methyl, A Gabi
物 二レン基、 及び nが 0である化合物) :商品名  Compound: Diylene group, and compound where n is 0): Product name
rp0lysantol」、 Fi置 nich社 g¾ rp 0 lysantol ", Fi device nich g¾
イソボルニルシクロへキサノール : 商品名  Isobornylcyclohexanol: Product name
- ― - 50 - - rsantalexj, Takasago社製  -―-50--rsantalexj, manufactured by Takasago
2-ェチル - 4-(2,2,3-トリメチル- 3-シクロペン  2-Ethyl-4- (2,2,3-trimethyl-3-cyclopent
テン- 1-ィル) -2-ブテン- 1-オール : 商品名 ― ― - - 50 - 「Bacdanol」、 IFF社製  -2-buten-1-ol: Product name ― ―--50-"Bacdanol", manufactured by IFF
2-メチル -4- (2, 2, 3-トリメチル- 3-シクロペン  2-Methyl-4- (2,2,3-trimethyl-3-cyclopent
テン- 1-ィル) -2-ブテン- 1-オール : 商品名 50 「SandalDiysore corej, Kao社製  Ten-1-yl) -2-Buten-1-ol: Product name 50 “SandalDiysore corej, manufactured by Kao
プロピレングリコール 50 50 50 50 50 50 材  Propylene glycol 50 50 50 50 50 50 Material
八き + 100 100 100 100 100 100 表中、 単位は重量%を示す。 各被験者に、表 1に示す組成物に含まれる芳香化合物を揮散させた状態の寝室で 就寝させた。なお、各被験者の就寝の 1時間前から、加熱式芳香用ホットプレートに 芳香剤組成物 0.5gを含浸させたフェルト(縦 35mm、横 15mm、厚さ 2mm;パルプ製) をおき、ホットプレートの温度を 80°Cに調整して芳香化合物を寝室内に揮散させて おき、就寝中の寝室内に芳香ィ匕合物の濃度が 5 X 10— 4ppm程度で一定に保持され るように調整しておいた。被験者には、就寝時にマイクロミニ R'R型ァクティグラフ(米 国 AMI社製;サタニ商事株式会社より入手)を非利き腕に装着させて、就寝中の身体 の微細な動きを測定し、数値化した。また、併せて「山本由華吏等、〃中高年,高齢者 を対象とした OSA睡眠調査票 (MA版)の開発と標準化"、脳と精神の医学、第 10卷、 第 4号、 1999年、第 401-409」で報告されている方法に従って、被験者に OSA睡眠調 查票の各項目について判定してもらい、起床時眠気、入眠と睡眠維持、夢み、疲労 回復、睡眠時間の各因子について評価した。 Yaki + 100 100 100 100 100 100 In the table, the unit is% by weight. Each subject was put to sleep in a bedroom where the aromatic compounds contained in the composition shown in Table 1 were volatilized. From 1 hour before bedtime of each subject, put felt (35mm long, 15mm wide, 2mm thick; made of pulp) impregnated with 0.5g of fragrance composition on a hot fragrance hot plate. adjust the temperature to 80 ° C were allowed to volatilize fragrance compound into the bedroom, adjusted so that is held constant at a concentration of about 5 X 10- 4 ppm aromatic I匕合was in the bedroom during sleep I kept it. The subjects put a micromini R'R type actigraph (manufactured by AMI, USA; obtained from Satani Shoji Co., Ltd.) on their non-dominant arm at the time of going to bed, and measured and digitized the minute movements of the sleeping body. . Also, together with “Yuka Yamamoto et al., Development and standardization of OSA sleep questionnaire (MA version) for middle-aged and elderly, elderly people”, Brain and Psychiatry, 10th, 4th, 1999, In accordance with the method reported in Section 401-409, subjects were asked to make a judgment on each item of the OSA sleep schedule. Each factor of recovery and sleep time was evaluated.
[0043] また、コントロールとして、表 1に示す組成物の代わりに、プロピレングリコールのみ( コントロール 1)又はサンダルウッド油(インドマイソール産) 50重量%及びプロピレン グリコール 50重量%を含む組成物(コントロール 2)を用いて、上記同様に評価を行 つた o  [0043] As a control, instead of the composition shown in Table 1, only propylene glycol (Control 1) or a composition containing 50% by weight of sandalwood oil (produced from Indomysole) and 50% by weight of propylene glycol (Control 2) ) And evaluated as above.
[0044] 得られた結果を図 1〜6に示す。図 1〜3には、ぞれぞれ実施例 1〜3の組成物の結 果を示し、;図 4〜6には、ぞれぞれ比較例 1〜3の組成物の結果を示す。また、図 1 〜6において、 Aには、マイクロミニ R'R型ァクティグラフにより測定した就寝中の活動 量(5人の被験者の平均値)(単位:ァクチグラフカウント数)を示し; Bには、 OSA睡眠 調査票の各項目の判定結果に基づいて、起床時眠気、入眠と睡眠維持、夢み、疲 労回復及び睡眠時間の各因子について数値化した結果 (5人の被験者の平均値)を 示す。各図の Aにおいて、就寝中の活動量が多い程、眠りが浅いことを示し、各図の Bにおいて、各項目の判定数値が大きい程、睡眠状態が良好であることを示す。  [0044] The obtained results are shown in Figs. Figures 1 to 3 show the results of the compositions of Examples 1 to 3, respectively; Figures 4 to 6 show the results of the compositions of Comparative Examples 1 to 3, respectively. In Figs. 1-6, A shows the amount of activity during sleep (average value of 5 subjects) (unit: actigraph count) measured by micromini R'R type actigraph; Shows the results of quantification of each factor of sleepiness at sleep, sleep onset and sleep maintenance, dream, recovery from fatigue, and sleep time based on the judgment results of each item of the OSA sleep questionnaire (average value of 5 subjects) Indicates. In A of each figure, the greater the amount of activity during sleep, the less sleep, and in B of each figure, the greater the numerical value of each item, the better the sleep state.
[0045] 図 1〜3に示すように、実施例 1〜3の組成物を使用した場合、就寝中の活動量が サンダルウッド油の場合と同程度又はそれ以下であり、優れた精神鎮静作用、安眠 誘発作用、或いはリラックス作用が発揮されていることが確認された。また、同様の傾 向は、 OSA睡眠調査の判定結果力もも確認された。特に、 OSA睡眠調査の判定結果 から、実施例 1〜3の組成物は疲労回復作用に優れていることが分力つた。一方、図 4〜6に示すように、比較例 1〜3の組成物は、実施例 1〜3の組成物と同様のサンダ ルゥッド系の芳香を呈しても、精神を鎮静させる作用や睡眠を改善する作用は備えて いないことが確認された。  [0045] As shown in FIGS. 1 to 3, when the compositions of Examples 1 to 3 are used, the amount of activity during sleeping is similar to or less than that of sandalwood oil, and has excellent mental sedation. It was confirmed that the effect of inducing sleep or relaxing was exerted. A similar trend was also confirmed in the OSA sleep survey results. In particular, from the results of the OSA sleep survey, it was found that the compositions of Examples 1 to 3 were excellent in fatigue recovery action. On the other hand, as shown in FIGS. 4 to 6, the compositions of Comparative Examples 1 to 3 have the effect of calming the mind and sleep even though they exhibit the same sandalous fragrance as the compositions of Examples 1 to 3. It was confirmed that there was no action to improve.
[0046] 実施例 4  [0046] Example 4
下記組成の香粧品(クリーム剤)を常法に従って調製した。  A cosmetic product (cream) having the following composition was prepared according to a conventional method.
単位:重量%  Unit:% by weight
3 ,3-ジメチル- 5-(2 , 2 ,3-トリメチル  3,3-dimethyl-5- (2,2,3-trimethyl
-3-シクロペンテン- 1-ィル) -4-ペンテン- 2-オール 0.10  -3-Cyclopentene-1-yl) -4-penten-2-ol 0.10
1, 3-ブチレングリコーノレ 3.00  1,3-Butyleneglycanol 3.00
カルボキシビ二ルポリマー(商品名「カーボポール 980」、 BF Goodrich社製) 0.20 Carboxyvinyl polymer (trade name “Carbopol 980”, BF Goodrich) 0.20
モノステアリン酸ポリオキシエチレン  Polyoxyethylene monostearate
(商品名「ィォネット T- 60C」、三洋化成製) 4.70  (Product name "IONET T-60C", manufactured by Sanyo Chemical) 4.70
ステアリン酸 1.00  Stearic acid 1.00
パルチミン酸セチル 2.00  Cetyl palmitate 2.00
ベへニノレアノレコール 3.00  Behenorenorecall 3.00
トリ 2—ェチルへキサン酸グリセリル 5.00  Tri-2-Ethylhexanoic acid glyceryl 5.00
スクヮラン 10.00  Skull 10.00
水酸化ナトリウム 適量  Sodium hydroxide appropriate amount
メチルパラベン 適量  Methylparaben appropriate amount
パラォキシ安息香酸エステル 適量  Paraxybenzoic acid ester
精製水 m _  Purified water m _
合計 100.00重量%  Total 100.00% by weight
例 5  Example 5
3,3-ジメチル- 5-(2, 2,3-トリメチル -3-シクロペンテン- 1-ィル) -4-ペンテン- 2-オール の代わりに、 3-メチル -5-(2,2,3-トリメチル - 3-シクロペンテン- 1-ィル) -ペンタン- 2-ォ ールを使用すること以外は、上記実施例 4と同様の組成で、香粧品(クリーム剤)を調 製した。  Instead of 3,3-dimethyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -4-penten-2-ol, 3-methyl-5- (2,2,3 A cosmetic (cream) was prepared with the same composition as in Example 4 except that -trimethyl-3-cyclopenten-1-yl) -pentane-2-ol was used.
[0048] 実施例 6 [0048] Example 6
3-メチル - 5-(2,2,3-トリメチル - 3-シクロペンテン- 1-ィル) - 4-ペンテン- 2-オールの 代わりに、 3-メチル -5-(2,2, 3-トリメチル -3-シクロペンテン- 1-ィル) -ペンタン- 2-ォー ルを使用すること以外は、上記実施例 4と同様の組成で、香粧品 (クリーム剤)を調製 した。  Instead of 3-methyl-5- (2,2,3-trimethyl-3-cyclopenten-1-yl) -4-penten-2-ol, 3-methyl-5- (2,2,3-trimethyl A cosmetic (cream) was prepared with the same composition as in Example 4 except that -3-cyclopenten-1-yl) -pentane-2-ol was used.
図面の簡単な説明  Brief Description of Drawings
[0049] [図 1]試験例 1において、実施例 1の組成物の精神鎮静効果及び睡眠改善効果等に ついて評価した結果である。 Aには、マイクロミニ R'R型ァクティグラフにより測定した 就寝中の活動量 (縦軸;単位はァクチグラフカウント数)を示し; Bには、 OSA睡眠調 查票の各項目の判定結果に基づいて、起床時眠気、入眠と睡眠維持、夢み、疲労 回復及び睡眠時間の各因子につ!ヽて数値化した結果 (縦軸;判定数値)を示す。 圆 2]試験例 1において、実施例 2の組成物の精神鎮静効果及び睡眠改善効果等に ついて評価した結果である。図中の A及び Bが表示する項目は、図 1の場合と同様で ある。 [0049] Fig. 1 shows the results of evaluating the mental sedation effect and sleep improvement effect of the composition of Example 1 in Test Example 1. A shows the amount of sleep activity (vertical axis; unit is the number of actigraph counts) measured by micromini R'R type actigraph; B shows the judgment result of each item of the OSA sleep survey form Based on sleepiness, wakefulness, sleep and sleep maintenance, dream, fatigue The numerical results (vertical axis; judgment value) for each factor of recovery and sleep time are shown.圆 2] In Test Example 1, the results of evaluating the mental sedation effect and sleep improvement effect of the composition of Example 2 are shown. Items displayed by A and B in the figure are the same as those in Figure 1.
圆 3]試験例 1において、実施例 3の組成物の精神鎮静効果及び睡眠改善効果等に ついて評価した結果である。図中の A及び Bが表示する項目は、図 1の場合と同様で ある。 圆 3] In Test Example 1, the results of evaluating the mental sedation effect and sleep improvement effect of the composition of Example 3 are shown. Items displayed by A and B in the figure are the same as those in Figure 1.
圆 4]試験例 1において、比較例 1の組成物の精神鎮静効果及び睡眠改善効果等に ついて評価した結果である。図中の A及び Bが表示する項目は、図 1の場合と同様で ある。 4) The results of evaluating the mental sedation effect and sleep improvement effect of the composition of Comparative Example 1 in Test Example 1. Items displayed by A and B in the figure are the same as those in Figure 1.
圆 5]試験例 1において、比較例 2の組成物の精神鎮静効果及び睡眠改善効果等に ついて評価した結果である。図中の A及び Bが表示する項目は、図 1の場合と同様で ある。 圆 5] The results of evaluating the mental sedative effect and sleep improving effect of the composition of Comparative Example 2 in Test Example 1. Items displayed by A and B in the figure are the same as those in Figure 1.
圆 6]試験例 1において、比較例 3の組成物の精神鎮静効果及び睡眠改善効果等に ついて評価した結果である。図中の A及び Bが表示する項目は、図 1の場合と同様で ある。 6) The results of evaluating the mental sedation effect and sleep improvement effect of the composition of Comparative Example 3 in Test Example 1. Items displayed by A and B in the figure are the same as those in Figure 1.

Claims

請求の範囲 一般式 (1)で表される化合物 Claims Compounds represented by general formula (1)
[化 1]  [Chemical 1]
Figure imgf000017_0001
Figure imgf000017_0001
[式中、 〜 は、同一又は異なって、水素原子、水酸基又はメチル基を示し、[Wherein, ~ are the same or different and each represents a hydrogen atom, a hydroxyl group or a methyl group,
R及び Rは、同一又は異なって、水素原子又はメチル基を示し、 R and R are the same or different and each represents a hydrogen atom or a methyl group,
8 9  8 9
Aは、エチレン基又はビ-レン基を示し、  A represents an ethylene group or a beylene group,
nは、 0〜 10の整数を示す]  n represents an integer of 0 to 10]
を含有することを特徴とする、鎮静用組成物。  A sedative composition comprising: a sedative composition.
[2] 一般式 (1)で表される化合物が、 [2] The compound represented by the general formula (1) is
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがェチレ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、  A compound wherein n is 0,
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがビ-レ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、又は  A group wherein n is 0, or
R〜R力 Sメチル基、 R〜Rが水素原子、 R及び R力 Sメチル基、 Aがビ-レン基で、 R ~ R force S methyl group, R ~ R is hydrogen atom, R and R force S methyl group, A is beylene group,
1 3 4 7 8 9 1 3 4 7 8 9
nが 0である化合物  n is 0
である、請求項 1に記載の鎮静用組成物。  The composition for sedation according to claim 1, wherein
[3] 芳香剤、香粧品、吸入投与剤、繊維製品用洗剤、又は食品の形態である、請求項 1 又は 2に記載の鎮静用組成物。 [3] The sedative composition according to claim 1 or 2, which is in the form of a fragrance, a cosmetic, an inhalation agent, a textile detergent, or a food.
[4] 一般式 (1)で表される化合物 [4] Compound represented by general formula (1)
[化 2]  [Chemical 2]
Figure imgf000017_0002
[式中、 〜 は、同一又は異なって、水素原子、水酸基又はメチル基を示し、
Figure imgf000017_0002
[Wherein, ~ are the same or different and each represents a hydrogen atom, a hydroxyl group or a methyl group,
R及び Rは、同一又は異なって、水素原子又はメチル基を示し、 R and R are the same or different and each represents a hydrogen atom or a methyl group,
8 9  8 9
Aは、エチレン基又はビ-レン基を示し、  A represents an ethylene group or a beylene group,
nは、 0〜 10の整数を示す]  n represents an integer of 0 to 10]
を含有することを特徴とする、睡眠改善用組成物。  A composition for improving sleep, comprising:
[5] 一般式 (1)で表される化合物が、 [5] The compound represented by the general formula (1) is
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがェチレ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is ethyl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、  A compound wherein n is 0,
R〜Rカ チル基、 R〜Rが水素原子、 R力 Sメチル基、 Rが水素原子、 Aがビ-レ R ~ R cation group, R ~ R is hydrogen atom, R force S methyl group, R is hydrogen atom, A is beryl
1 3 4 7 8 9 1 3 4 7 8 9
ン基、 nが 0である化合物、又は  A group wherein n is 0, or
R〜R力 Sメチル基、 R〜Rが水素原子、 R及び R力 Sメチル基、 Aがビ-レン基で、 R ~ R force S methyl group, R ~ R is hydrogen atom, R and R force S methyl group, A is beylene group,
1 3 4 7 8 9 1 3 4 7 8 9
nが 0である化合物  n is 0
である、請求項 4に記載の睡眠改善用糸且成物。  The sleep improving yarn and adult product according to claim 4, wherein
[6] 芳香剤、香粧品、吸入投与剤、繊維製品用洗剤、又は食品の形態である、請求項 4 又は 5に記載の睡眠改善用組成物。 6. The composition for improving sleep according to claim 4 or 5, which is in the form of a fragrance, a cosmetic, an inhalation agent, a textile detergent, or a food.
PCT/JP2006/314958 2005-07-28 2006-07-28 Sedative composition WO2007013581A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005219377A JP4632895B2 (en) 2005-07-28 2005-07-28 Sleep improvement composition
JP2005-219377 2005-07-28
JP2006035834A JP2007031421A (en) 2006-02-13 2006-02-13 Composition for sedation
JP2006-035834 2006-02-13

Publications (1)

Publication Number Publication Date
WO2007013581A1 true WO2007013581A1 (en) 2007-02-01

Family

ID=37683468

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/314958 WO2007013581A1 (en) 2005-07-28 2006-07-28 Sedative composition

Country Status (1)

Country Link
WO (1) WO2007013581A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008146883A1 (en) * 2007-05-29 2008-12-04 Osaka Bioscience Institute Sleep-improving agent

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63199292A (en) * 1987-02-13 1988-08-17 高砂香料工業株式会社 Perfume composition and cosmetics containing the same
JPH0328300A (en) * 1989-06-26 1991-02-06 Kanebo Ltd Essential oil and perfume containing same essential oil
JPH07316582A (en) * 1994-05-21 1995-12-05 Shiseido Co Ltd Sleep-inducing perfume composition
JPH1025245A (en) * 1996-07-11 1998-01-27 Kobayashi Pharmaceut Co Ltd Oral hypnotic agent, hypnotic beverage and food, and hypnotic feed
JP2000109457A (en) * 1998-08-17 2000-04-18 Givaudan Roure Internatl Sa Oxime carboxylic acid derivative
WO2002049600A1 (en) * 2000-12-20 2002-06-27 Quest International B.V. Perfume compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63199292A (en) * 1987-02-13 1988-08-17 高砂香料工業株式会社 Perfume composition and cosmetics containing the same
JPH0328300A (en) * 1989-06-26 1991-02-06 Kanebo Ltd Essential oil and perfume containing same essential oil
JPH07316582A (en) * 1994-05-21 1995-12-05 Shiseido Co Ltd Sleep-inducing perfume composition
JPH1025245A (en) * 1996-07-11 1998-01-27 Kobayashi Pharmaceut Co Ltd Oral hypnotic agent, hypnotic beverage and food, and hypnotic feed
JP2000109457A (en) * 1998-08-17 2000-04-18 Givaudan Roure Internatl Sa Oxime carboxylic acid derivative
WO2002049600A1 (en) * 2000-12-20 2002-06-27 Quest International B.V. Perfume compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIMOGLO A.S. ET AL.: "Investigation of the relationship between sandalwood odor and chemical structure: electron-topological approach", NEW JOURNAL OF CHEMISTRY, vol. 19, no. 2, February 1995 (1995-02-01), pages 149 - 154, XP002067557 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008146883A1 (en) * 2007-05-29 2008-12-04 Osaka Bioscience Institute Sleep-improving agent
JPWO2008146883A1 (en) * 2007-05-29 2010-08-19 財団法人大阪バイオサイエンス研究所 Sleep improver

Similar Documents

Publication Publication Date Title
JP5007833B2 (en) Autonomic nerve regulator
CN103222931B (en) Composition containing menthofuran and menthol
JP5025845B2 (en) Method and agent for enhancing perfume fragrance and sustainability
JP2002080336A (en) Body odor inhibitor and application thereof
JP2009235015A (en) Autonomic nerve regulator
JP2012246278A (en) Psychic energizer and psychic energizer composition
JP2007197334A (en) Composition for autonomic nerve regulator, sleep improving agent or stress relaxant
JP4632895B2 (en) Sleep improvement composition
JP2008247894A (en) Stress response ameliorating agent
WO2007013581A1 (en) Sedative composition
JP5019016B2 (en) Sleep improver and fragrance preparation
JP2652552B2 (en) Composition for inhalation administration to calm the consciousness level
JP2007031421A (en) Composition for sedation
JP2005206596A (en) Aromatherapeutic composition
JP2009051770A (en) Appetite suppressant composition
JP4547193B2 (en) Fragrance composition
JPH01254629A (en) Agent for raising consciousness level
JP2005206597A (en) Sedative or sleeping composition, sedative or sleeping material, and odorizing product given by using the same
WO2005033254A1 (en) Body fat burn spurring perfume composition
JP2005029776A (en) Perfume composition
JP2002154951A (en) Brain wave inhibitor
JP2676543B2 (en) Awareness lowering agent
JPH11343497A (en) Cosmetic
JPWO2009113287A1 (en) Aromatic antihypertensive agent
JP2007031347A (en) Composition for psychosedation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06781868

Country of ref document: EP

Kind code of ref document: A1